Top ▲
Target not currently curated in GtoImmuPdb
Target id: 1615
Nomenclature: Endothelin-converting enzyme 1
Abbreviated Name: ECE1
Family: M13: Neprilysin
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 1 | 770 | 1p36.12 | ECE1 | endothelin converting enzyme 1 | |
Mouse | 1 | 769 | 4 D3 | Ece1 | endothelin converting enzyme 1 | |
Rat | 1 | 762 | 5q36 | Ece1 | endothelin converting enzyme 1 |
Previous and Unofficial Names |
ECE-1 | ECE |
Database Links | |
Specialist databases | |
MEROPS | M13.002 (Hs) |
Other databases | |
Alphafold | P42892 (Hs), Q4PZA2 (Mm), P42893 (Rn) |
BRENDA | 3.4.24.71 |
CATH/Gene3D | 3.40.390.10 |
ChEMBL Target | CHEMBL4791 (Hs), CHEMBL2676 (Rn) |
Ensembl Gene | ENSG00000117298 (Hs), ENSMUSG00000057530 (Mm), ENSRNOG00000014241 (Rn) |
Entrez Gene | 1889 (Hs), 230857 (Mm), 94204 (Rn) |
Human Protein Atlas | ENSG00000117298 (Hs) |
KEGG Enzyme | 3.4.24.71 |
KEGG Gene | hsa:1889 (Hs), mmu:230857 (Mm), rno:94204 (Rn) |
OMIM | 600423 (Hs) |
Orphanet | ORPHA121255 (Hs) |
Pharos | P42892 (Hs) |
RefSeq Nucleotide | NM_001113348 (Hs), NM_001113347 (Hs), NM_001113349 (Hs), NM_001397 (Hs), NM_199307 (Mm), NM_053596 (Rn) |
RefSeq Protein | NP_001388 (Hs), NP_001106820 (Hs), NP_001106819 (Hs), NP_001106818 (Hs), NP_955011 (Mm), NP_446048 (Rn) |
UniProtKB | P42892 (Hs), Q4PZA2 (Mm), P42893 (Rn) |
Wikipedia | ECE1 (Hs) |
Enzyme Reaction | ||||
|
Endogenous substrates (Human) |
endothelin-1 (EDN1, P05305), endothelin-2 (EDN2, P20800), endothelin-3 (EDN3, P14138) |
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific inhibitor tables |
Clinically-Relevant Mutations and Pathophysiology | ||||||||||
|
||||||||||
|
1. Ahn K, et al. (1996) Quinazolines as inhibitors of endothelin converting enzyme. Patent number: WO1996019474. Assignee: Warner Lambert. Priority date: 22/12/1994. Publication date: 22/06/1996.
2. Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V. (2010) Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors. J Med Chem, 53 (1): 208-20. [PMID:19899765]
3. Seed A, Kuc RE, Maguire JJ, Hillier C, Johnston F, Essers H, de Voogd HJ, McMurray J, Davenport AP. (2012) The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans. Life Sci, 91 (13-14): 743-8. [PMID:22480515]
4. Umekawa K, Hasegawa H, Tsutsumi Y, Sato K, Matsumura Y, Ohashi N. (2000) Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme. Jpn J Pharmacol, 84 (1): 7-15. [PMID:11043447]
M13: Neprilysin: Endothelin-converting enzyme 1. Last modified on 21/07/2015. Accessed on 09/09/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1615.